Bank of Nova Scotia
ORIA

Bank of Nova Scotia’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Bank of Nova Scotia’s Portfolio ORIA Stock Details ORIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-40,000
Closed -$409K – 1199
2023
Q1 		$409K Hold
40,000
– – ﹤0.01% 896
2022
Q4 		$404K Hold
40,000
– – ﹤0.01% 951
2022
Q3 		$394K Hold
40,000
– – ﹤0.01% 1006
2022
Q2 		$390K Hold
40,000
– – ﹤0.01% 1053
2022
Q1 		$390K Hold
40,000
– – ﹤0.01% 1084
2021
Q4 		$387K Buy
+40,000
New +$393K ﹤0.01% 1127

Bank of Nova Scotia's ORIA Position: Q2 2023 in Review

Bank of Nova Scotia sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 40,000 shares — an estimated $409K sold.

Bank of Nova Scotia first reported a position in ORIA in Q4 2021 and held it in 6 quarters. The position peaked at $409K in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

  • Bank of Nova Scotia reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
  • Bank of Nova Scotia sold 40,000 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $409K.
  • Bank of Nova Scotia first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q4 2021 and held it in 6 quarters.
  • Bank of Nova Scotia's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $409K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Bank of Nova Scotia's 13F filing for Q2 2023, filed 3 Aug 2023.